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Background and Objective: Application of genetically modified organisms in the agriculture 
sector and food industry began since last years of 20th century. Since then this technology has 
become a central part of the broader public controversy about the advantages and safety of 
these products. This article has tried to review aspects of these types of organisms and foods. 
Results and Conclusion: Genetically modified technology has potential to overcome 
agricultural problems, such as biotic and abiotic issues by enhancing pests and herbicides 
resistance, drought tolerance, fast ripening, and finally enhancing yield and nutritional quality. 
Besides these revolutionary advantages, during the last decades some potential human, animal 
and environmental risks have been taken in account for these organisms or foods. However, 
no scientific evidence exists adequately about their harmful human or animal effects, and also, 
some new scientific and management methodologies (new technologies and regulations) have 
been developed to mitigate the environmental risks. Some challenges such as pest adaptation 
are being solved by refuge technology, gene pyramiding and insertion of best-coupled primers 
through the known conditions reducing unintended outcomes including silencing, activation 
or rearrangement of non-target genome pieces. However, it does not mean that no harmful 
effect will happen in the future. Therefore, it is required that before release of any genetically 
modified crop, all requested risk assessments be performed, and then post release monitoring 
be done to follow the possible gene flow and prevent any potential disastrous contaminations 
to the food chain. Finally, it could be concluded that the safe usage of this technology, by 
considering all nationally and internationally accepted environmental and health safety 
assessment protocols, can help us to use advantages of this technology in agriculture, 
medicine and industry. However, more safety evaluations are being done frequently.  
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According to the definition of World Health 
Organization (WHO), genetically modified organisms 
(GMOs) include plants and animals which are modified 
genetically rather than conventional breeding approaches. 
So, a GMO is an organism whose genome has been altered 
by the techniques of genetic engineering at in vitro level so 
that its DNA contains one or more genes or other gene 
expression elements not normally found there. In 1994, the 
US Food and Drug Administration (FDA) has approved 
the first genetically modified (GM) tomato (Flavr Savr) 
containing delayed ripening characteristics [1]. After that 
various GM varieties of different plant species have been 
approved to be released in the environment or to be used as 
food, feed or for processing. For instance, several GM 
varieties of canola, cotton, soybean, potato, eggplant, 
strawberry and carrot have been approved by FDA during 
recent years [2]. The first generation of GM crops has been 
developed for yield and quality improvement by inducing 
pests, disease, drought and herbicides resistance, and 
salinity and cold tolerance. However, the second gene-
ration of GM crops is in pipeline for improvement of 
nutritional quality and also production of recombinant 
pharmaceutical proteins (molecular farming) [3]. Recently, 
DNA sequences have been extracted from soil bacteria and 
plant pathogenic bacteria and viruses. Their insertion 
occurs by one of the two principal methods, which are 
Agrobacterium-mediated transformation and micro-pro-
jectile bombardment [4]. Crops have been drastically 
changed by genetic engineering; nonetheless, gene per-
formance can be affected simultaneously by the envi-
ronment and in-farm practices. Environmental factors are 
as effective as intrinsic parameters. It was shown that heat 
was more important than genetic modification in 
expression of anti-nutrients in crops including maize, 
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potato, tomato, and soybean. For example, Arabidopsis 
disease resistance is attributed to DNA methylation. It was 
found that environmental factors affecting methylation 
process or chromatin conformation would induce gene 
silencing and different results would be seen. So, their final 
performance would also be pertained to geographic loca-
tion and method of cultivation [5,6]. Besides revolutionary 
advantages of GM crops during last decades, some 
potential human, animal, and environmental risks have 
been taken in account for GM organisms or foods. A large 
number of experiments and data are needed to enable 
scientists to determine the safety of GM corps and their 
likely health concerns [7]. Therefore, the aim of this 
review article is to gather previous findings, current 
evidence, types of assessment, and legislations associated 
with genetically modified products to alleviate ambiguities 
arising from this technology. 
Potential promises associated with GM 
foods 
Current world population is more than 7 billion [1] and 
it is anticipated that it will raise to 9.3 billion in 2050 [8]. 
According to FAO, 795 million people suffered from 
malnutrition in the world in 2015 [9]. Increasing world 
population and feeding demands should be correlated with 
increasing yield to comply the overall demands. Paucity of 
food (food insecurity), water and arable lands have forced 
governments to develop genetic engineering technology. 
Genetic engineering has been taken in account as one of 
important technologies which can have a key role in 
overcoming such problems in the agriculture sector. 
Countries with high population such as China and with 
dense population and narrow arable land, such as Japan, 
have extensively invested in GM crops. In 2015, 3.7 
million hectares were planted with GM crops in China. 
Chinese governments have paid more than 3 billion dollars 
on GM research for domestic GM seed development 
paralleled to their testing and approval [10]. To date, GM 
crops are planted widely worldwide. In 2016, 185.1 million 
hectares (equal to 457.4 million acres) were cultivated by 
18 million farmers in 26 countries. This statistic shows an 
increase of 3% or 5.4 million hectares (13.1 million acres) 
compared to 2015 [11]. It was investigated that planting of 
GM crops reduced about 27 million tons of CO2 emission 
in 2014 [12]. Aggregation of benefits including low cost, 
improvement of nutrients in the same crops and the most 
important lowering mortality and malnutrition has made 
GM technology popular in some societies [13].  
Development of crops characterized with delayed ripe-
ning, resistance to insecticide, herbicide, drought, black 
spot, viral disease, and fusarium infection are other 
positive outcomes of GM technology [1,14]. In some 
cases, the purpose of genetic engineering is bio-forti-
fication by health promoting agents such as vitamins, fatty 
acids, and minerals especially in staple crops. Indeed, the 
first generation is aimed at increasing yield and the second 
generation is designed for quality improvement [15]. 
Regarding the latest traits, it would be applicable to use 
transgenic crops as oral vaccines to stimulate the immune 
system in producing antibodies. Some crops including rice, 
maize, soybeans and potatoes are understudying against 
Escherichia coli, rabies virus, Helicobacter pylori and type 
B viral hepatitis [1]. Genetic engineering can produce 
hypoallergenic soybean or altered qualified analogues with 
the same allergenicity [16]. 
Another example is GM maize expressing crystal (cry) 
proteins from Bacillus thuringiensis (Bt) to diminish insect 
damage and fumonisin infection in comparison to non-GM 
counterparts [17]. Using Bt toxins is considered as the 
most widely applied approach since the evolution of GM 
crops [18]. It has been approved by WHO and Envi-
ronmental Protection Agency (EPA) and has no safety 
concerns for humans owing to its specificity to target 
organisms [19,20]. Cultivation of Bt crops decreased the 
amount of chemical insecticide in South Africa over 20 
years [21]. The mechanism is that the cry proteins attack to 
the mid-gut of insects and make lesions or wounds in host 
epithelial cell membrane which results in septicemia. In 
contrast, it is safe for humans because there is no 
equivalent receptor in human gut for cry protein [22,23]. 
Besides horticultural effect, it is environment friendly due 
to lowering chemical insecticide consumption [17].  
Soil organisms are firstly exposed to Bt toxins after 
crop death. They have the drastic roles such as nitrogen 
fixation, growth promotion, and nutrient solubilization. 
Therefore, the effect of cry protein should be investigated 
in risk assessment. It has been revealed that there is 
negligible or no concern about its harmful effect on soil 
ecosystem. No adverse effect on soils vital organisms such 
as mites, collembola, and earthworm was shown in 
experiments and field studies [23]. One exception is 
lowered growth in exposed snails to Bt maize [24]. 
A large number of Bt cottons is cultivated in Pakistan 
in recent years with yield increment by 28% and pesticide 
cost reduction by 17% over non-Bt varieties. Reduced 
pesticide use has produced health and environmental 
benefits of 79$ per acre [25]. Increased yield has also 
generated substantial female employment effects in the 
country [26]. Nevertheless, Bt cotton adoption in India has 
reduced pesticide use more than 50% during 6 years [27]. 
No adverse histo-pathological changes were observed in 
the study of rabbits’ liver and kidney, which were treated 
by seeds and leaves of Bt (alteration in Cry1Ac Mon 531 
gene) and non-Bt cottons during 90 days. They also did not 
show any significant differences in weight gain. It was 
found that Bt gene did not cause detrimental changes to the 
DNA integrity [28]. One other achievement in Bt maize 
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technology was control of fusarium infection. Mycological 
analysis based on ergosterol measurement (as specific 
component of fungal membrane) [29] revealed that 
ergosterol level in Bt maize was 4-18 times lower than 
control hybrids [30]. Some other characteristics could be 
transferred to cotton; for example, luster, softness, good 
elasticity and warmth retention property were induced in 
engineered cotton varieties by importing animal keratin 
genes [10]. 
Regarding Bt corn, another study verified no 
allergenicity over 30 years of commercial use and no 
occupational allergenicity through its modification was 
observed. In comparison to the control and GM coun-
terparts, no meaningful compositional, phenotype and 
micronutrient level was found [4]. 
Other than Bt crops, genetically engineered rice (Xa21) 
was also evaluated. Like other GM foods, no detrimental, 
toxic and allergenicity consequences were reported for GM 
rice. In practice, 3 fold up expression of pullulanase was 
measured in proteomics studies over the control. Pull-
ulanase is responsible for the alteration of starch structure 
in rice endosperm by its enzymatic (de-branching) activity 
[31]. Further, higher expression of glutamic acid (23.40% 
vs. 19.38%) observed in GM rice which was interestingly 
within the reference range reported previously [32]. 
Herbicide tolerance (such as phosphinothricin tole-
rance) is another approach in genetic engineering. Crops 
containing the gene encoding Phosphinothricin-N-
acetyltransferase (with no known toxic effect) extracted 
from aerobic soil actinomycete and Streptomyces 
hygroscopicus, tolerate glufosinate (an active ingredient in 
herbicide which is resemble with amino acid glutamic). 
Glufosinate interferes in enzyme glutamine synthase 
activity and lead to lower glutamine level and ammonium 
accumulation in plants. This results in plant withering and 
death by disruption of cell membrane and cease of 
photosynthesis. Herbs resistant to glufosinate by enzyme 
degrading phosphinothricin and changing it to inactive 
compound can grow in the farms sprayed with herbicides 
[33]. 
Potential challenges associated with 
GM foods 
Despite the advantages of GM crops mentioned above, 
some scientists raised environmental and health concerns 
about these products and believe that GM technology has 
failed in recent decades. They worry about its serious 
threats to the biodiversity, evolution of resistant pests, and 
side effects impacting humans and animals as well as the 
environment [34]. For instance, there was a demand on 
GM free wheat by the buyers in 2013 when the unexpected 
glyphosate resistant wheat was found in Oregon farms and 
made a threat for the U.S. trade with GM opt-out countries 
including Japan, South Korea and European Union [14]. In 
contrast, situation is different in America. The U.S is the 
most investor and producer of GM foods and half of global 
GM crops are cultivated there through science-based 
institutions assisted with risk assessment approaches. Thus, 
it is obvious that American governors and traders have less 
rigorous regulations on GM compared to European 
countries. While Canada is the biggest canola producer, 
Mexico is not against GM crops as much as Europe but it 
is reluctant to approve GMOs beyond pilot trials [13]. 
Almost 90% of GMOs are taken by consumers through 
GM derivatives made in industry and just about 10% are 
consumed directly [35]. The Cartagena Protocol on 
Biosafety is the most important obligatory regulation on 
safe trade of living modified organisms. By 2017, about 
171 countries are as members of this protocol. One of the 
most important principles in the CPB is risk assessment 
and consequently risk management [36]. 
As a rule, risk assessment should consider all aspects of 
DNA recombination so that the final product and also the 
method of cultivation have not had unexpected adverse 
effects on both human and the ecosystem. Based on the 
CPB protocol, risk assessment should be performed in a 
scientific manner and case by case. Clinical adverse effects 
are pertained to disruption, activation or silencing of 
existent genes or any other changes such as rearrangement 
[4,32]. Concerning the ecosystem, it is necessary to 
investigate the possible effects on water, soil, air and 
animals owing to potential harms associated with GM 
release into the environment. Main human safety concerns 
are related to their toxicity, allergenicity, and other 
possible hazards arising from inserted genes, expressed 
proteins, potential pleiotropic effects due to metabolites 
other than the target protein, and non-target change in gene 
integrity due to its manipulation. In biosafety, there is a 
difference between animals and plants. In general, animals 
having a safe history of use in dietary patterns do not have 
genes encoding for harmful metabolites. But, the situation 
is different in plants. There are some plants which are safe 
for use but contain toxic agents that require detoxification 
before consumption. Some examples are ricin in castor 
bean, trypsin inhibitors in soybean, etc. This issue is not 
restricted to gene engineering and affects conventional 
breeding as well [37].  
Unintended outcomes must be assessed in general. 
They might not be deleterious necessarily and might pose 
beneficial or neutral role in plants or foods derived from 
them [4]. In risk assessment approaches, it is important to 
find out that if the novel protein would induce a secondary 
effect on plant or human. On the other hand, expression of 
proteins as intended target may result in the accumulation 
of secondary metabolites [37] or the modification may 
mediate new enzyme production involved in other 
metabolic pathways and participates in new metabolite 
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production [1]. Therefore, the role and activity of 
secondary products should be investigated critically. 
One challenge is to set a qualified method in the 
analysis of new traits. For example, engineered rice for 
reduction of glutelin level was associated with the increase 
of prolamin. Both of them are a type of gluten protein and 
are responsible for allergenicity in coeliac disease. It was 
found that new change could not be detected by standard 
nutritional analysis including total protein and amino acid 
profile and the difference was detected just by sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis. Diff-
erences like this would not influence the industrial 
application, but nutritional quality and further allergenicity 
would change especially when it occurs in staple foods 
such as rice. Same results were observed in production of 
Golden Rice. Aim of this design was production of high 
level of beta-carotene in rice as precursor of vitamin A. 
This change was unexpectedly accompanied by higher 
production of xanthophylls, so that it could not be detected 
by standard nutritional analysis and high pressure liquid 
chromatography was used alternatively [4]. 
Some other drawbacks are also addressed to GM 
technology. Insertion of resistance gene into crops had led 
to the resistance of target pests. A known example in 
recent years is evolution of resistant insects to Bt crops 
containing gene encoding cry proteins. Although, this 
phenomenon was solved temporarily by a strategy named 
“refuge” including cultivation of non-Bt crops near the Bt 
counterparts. Refuge limits and delays the domination of 
resistant pests significantly [17]. There are several 
parameters that should be considered for controlling this 
process. Resistance severity depends on type of pests. 
Propagation of resistance would occur by mating of 
resistant and susceptible pests in farms. Then, if the hybrid 
gene is not recessive, the new trait would evolve. More-
over, the ratio of refuge and transgene is determinative. On 
the other hand, dominance of resistance and refuge 
abundance are in a counter relation to each other. Using 
higher percentage of refuge would prolong the period of 
resistance evolution. For example, in the case of 
Helicoverpa zea, using 70% refuge compared to 30% 
transgene required more than 20 years for resistance 
evolution [38]. Another strategy is gene pyramiding in 
which many Bt genes are transferred to the genome of 
crops to delay pest resistance. In this way, insects are faced 
with multiple toxins [39]. Nonetheless, increased yield is a 
promise of GM technology that cannot be neglected. 
Consideration of all effective parameters is a proper 
alternative to combat the mentioned drawbacks. 
Horizontal gene transfer is a process in which DNA 
would transfer between organisms (plants, animals and 
microorganisms) interchangeably. There is a concern in 
gene exchange and contradictive opinions are reported. 
Some studies report that gene interchange occurs rarely, 
while other studies declare that transgenes could be taken 
by the environment or consumers’ digestive bacteria. 
There is a claim that the acidic environment in digestive 
tract and thermal process would degrade ingested foreign 
genome by transgenic foods [40]. Although, adverse state-
ments are based on hypothesis and no proven evident has 
been introduced but the possibility should not be 
completely discounted and considering widespread usage 
and abundant diversity of transgenes in the world may 
make it possible in the near future [34]. It is worth saying 
that gene transfer from one organism to another is a 
complex process and needs consecutive stepwise events 
[7]. 
One controversial issue in GM technology is the 
insertion of antibiotic resistance genes as natural markers. 
This approach is to insure scientists that the target gene has 
been inserted into the cells. In practical, plants containing 
new genes would be resistant to antibiotic while other 
counterparts cannot grow. For example, two plasmids 
containing bla gene were used in soybean transformation. 
The bla gene is responsible for the expression of lactamase 
enzyme which degrades lactam antibiotics such as 
penicillin and ampicillin [4]. Although, it is accepted as a 
safe pathway because of their widespread persistence and 
rare possibility of transfer [41], but some GM critics worry 
about transfer and expression of antibiotic resistant genes 
to inhabitant bacteria in gastrointestinal tract. It should be 
noted that transfer process would occur by stepwise events 
that make it unlikely. 
The process is as below: 
 Excision of gene encoding antibiotic resistance together 
with bacterial promoter 
 Survivability of that gene in gastrointestinal tract 
 Transfer of survived gene into bacteria in gastrointestinal 
tract 
 Compatibility of target gene with bacterial system to-
wards joining host genome 
 Stable integration of target gene containing antibiotic 
resistance trait into host genome 
 Keeping integrity and further expression in host bacteria 
 
Other than the complexity of process, there is a fact 
that bacteria present in digestive tract are already resistant 
to ampicillin. Therefore, even by neglecting the low possi-
bility of bla gene transfer to digestive tract bacteria, there 
would not be any health concerns about bacterial resistance 
to lactam antibiotics such as ampicillin which is rarely 
advised clinically in recent years [4]. Environmental 
disasters including pollution derived from the longtime use 
of herbicides and biodiversity reduction are some 
difficulties associated with this technology [22]. Studies 
stated that use of herbicides and pesticides would increase 
after evolution of GM resistant plants. Acclimation of 
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weeds and insects to in-farms chemicals forced farmers to 
use more amounts of chemicals or use other more efficient 
alternatives which might have more adverse effects on 
human, animals and the environment. Comparative studies 
show that the use of glyphosate have been increased with a 
sharp trend since 2005 [42].  
Glyphosate used for GM plant protection would 
ultimately release into the soil and stimulate the growth of 
fungus, Fusarium. The fungus can induce botanical 
infection [43]. Fusaria have a potentiality of toxin 
production, which have carcinogenic and cytotoxic effects 
[44]. The International Agency for Research on Cancer 
(IARC) has classified glyphosate in group 2A. It means 
that it is “probably carcinogen for human”. Although, the 
European Food Safety Authority (EFSA) believes that 
glyphosate does not cause carcinogenicity if used within 
the range of maximum residue limits [45]. It has been 
proved that glyphosate affects soil’s living organisms 
differently depending on dosage, number of applications 
and biochemical conditions of soil. For example, soil’s pH 
has a discriminative role so that microbial growth would be 
inhibited strongly in neutral soils than acidic or alkaline 
media or in soils with the lower levels of organic carbon. 
Following microbial degradation, the pHs out of neutral 
point induce mineralization and binding of phosphor 
moiety to soils’ reactive components such as minerals. 
Therefore, the lowered toxic sequence on plant and soil 
microbes is expected because of the unlikely degradation 
by quenched metabolites as a result of their lower potential 
of penetration to cell membranes. Also, lower organic 
carbon causes the lower buffering strength, which makes 
plants more sensitive to stress factors [46]. 
In general, it is important to distinguish between 
hypothesis and proved health problems. Although, the 
higher use of chemicals in response to the acquired 
resistance of pests due to continued consumption of 
chemicals is reported, more expanded investigations by 
focusing on risk assessment of human and the ecosystem 
are required. A breadth of expertise in agriculture, 
veterinary medicine, microbiology, food technology, and 
immunology should collaborate to produce comprehensive 
safety guidelines concerning the GM products [1]. 
Furthermore, ethical issues should be considered by the 
governments. Mentioning GM source on food labeling 
gives a choice to consumer in selection of food items. 
Number of unintended metabolites can be reduced by exact 
deposition of promoter and terminator sequences in the 
way that confirm the right transcription of target gene and 
expression of intended protein [47]. 
General safety evaluation 
Food safety issues of GM crops were investigated 
comprehensively by Codex Alimentarius Commission. 
These issues had been more focused by emergence of food 
labeling guidelines for consumer awareness [7]. Since 
then, this technology has become a central part of broader 
public controversy about safety on prolonged consumption 
of these food products. There has been a severe concern 
that GM products may act adversely as toxins, anti-
nutrients, and allergens [32]. Therefore, more safety 
evaluations should be done, for instance, toxicological 
studies by animal model system at least during 90 days in 
sub-chronic trials, and through long term cohort studies in 
societies [10,48]. However, no adverse safety effects on 
human have been currently reported for more than 20 years 
consumption of GM foods in the World [35]. Scientists are 
seeking the minimum copy and size of DNA inserted in 
host plants to facilitate risk assessments and consequently 
the regulatory trends. It is pointed out that multiple 
insertions would not result in lower safety necessarily. 
However, various transformations may occur due to 
random insertion. Furthermore, phenotype-based approach 
in small scale cultivation as an initial screening can remove 
undesirable traits or events before vast cultivation. If crops 
can pass through this stage, which is done by breeders, 
they would undergo the safety assessment [4]. 
Unintended effects are subdivided into “predictable” 
and “unpredictable” [49] and could be analyzed by 
genomic strategies with the aid of bioinformatics tools 
[50]. In a comparative approach, three factors are consi-
dered: a) molecular characterization, b) phenotypic 
characterization, and c) compositional analysis [37]. New 
proteins are expressed as low as 0.1 percent of plant tissue 
per dry weight. While, in biosafety studies, large amounts 
of protein expression are required. So, bacterial expressed 
proteins are purified and used instead. In such studies, fun-
ctional equivalence including physiochemical properties 
and biological activities of both sources of proteins are 
needed [4]. 
Risk assessment 
Risk assessment is a helpful approach in monitoring 
hazards arising from foods. The approach consists of 
hazard identification and characterization by toxicological 
studies, exposure assessment through epidemiological 
studies and risk characterization by considering achieved 
data. Diminishing variability and uncertainty in risk 
assessment is important for further process [51]. Risk 
assessment of GM crops has been conducted during more 
than two decades worldwide by considering three aspects: 
1) physiology of crops affecting evolution of specific 
hazards (e.g. trypsin inhibitors in soybean, solanine in 
potato, erucic acid in canola oil etc.), 2) dietary exposure 
which relates to sequence of consumption by human, 3) 
possibility of health concern regarding characterized 
hazards [52]. In detail, risk assessment in GM foods 
consists of molecular characterization of gene sequencing, 
similarity tests compared with counterpart allergens or 
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toxins, protein toxicity tests, quantitative studies of new 
traits or metabolites, nutritional equivalence studies, 
animal studies, and also dietary exposure [47]. In this 
process, a safe history of conventional counterpart is used 
as baseline and a relative safety of modern crop to 
conventional samples with a long history of safe use is 
monitored or evaluated [53]. Correspondingly, the GM 
food is expected to be as safe as its conventional analogue 
under controlled processing and consumption. It means 
that GM crops must be substantially equivalent to 
conventional crops except in their new added traits [4]. 
Although critical hazards and risks must not be neglected, 
emerging GM technology by various promising expec-
tations should be evaluated as a whole and further 
decisions should be taken based on the risk-benefit 
comparisons in risk management step [48]. This 
justification arises from the fact that natural crops may 
have some adverse components such as solanine in potato 
or allergenic proteins in soybean. The joint Food and 
Agriculture Organization (FAO)/World Health Organi-
zation (WHO) expert consultation has declared that safety 
assessment needs stepwise approaches; in comparison, 
substantial equivalent is different from safety assessment 
as it does not identify and characterize hazards but should 
be used for identifying safety assessment of conventional 
crops compared with recombinant counterparts [4]. In risk 
management step, based on obtained information, analyzed 
results and current policies, the level of acceptable risk 
would be determined by managers and they decide to 
accept or reduce existent risks [54]. This is the fact that 
prefers food security to food safety in societies. The 
Biosafety Clearing-House constructed by the Cartagena 
Protocol on Biosafety is to exacerbate sharing information 
about living modified organisms and help members to 
comply their commitments by using released protocol. 
Essential information including characteristics of 
promoters, terminators and gene encoded are illustrated for 
each product. Roots of risk assessments based decisions on 
registered GMOs are accessible [55]. 
Assessing the safety of newly expressed protein has a 
general procedure as elaborated below: 
Depending on the source of expressed protein in target 
crops, two assessment procedures are used. When the 
source is allergenic, both sequence homology and potential 
allergenicity of protein by serology tests would be 
conducted [56]. In practice, when sequence homology to a 
known allergen is proved, the GM crop is classified as 
allergen and no further studies are needed. One example is 
GM soybean enriched with methionine which is allergen to 
sensitive individuals [2]. Similarly, gene encoding the 
amino acid extracted from Brazil nuts is also allergen. In 
contrast, when no sequence homology to a known allergen 
is shown, serological test for expressed proteins is done by 
serum samples containing high levels of IgE specified to 
gene source [57]. When serological test is positive, the 
protein would be allergen. In comparison, when a negative 
result is achieved, gastric digestion by pepsin resistance 
test and also animal study on immunogenicity of expressed 
protein are undertaken. In the next step, additional safety 
assurance can be provided once GM product is released in 
the market. This survey is recommended because of the 
wide genetic diversity in populations and different dietary 
patterns depending on geographical residence [58]. Finally, 
determination of proximate composition is favorable [4]. If 
composition of engineered crops changes, further inves-
tigation is recommended to assess the changes of nut-
ritional status and bioavailability of components in daily 
intake [37]. 
Additional issues should be focused when viable 
organisms are present in final product such as fermented 
foods. Significant issues include antibiotic resistance and 
possibility of their gene transfer, pathogenicity, immu-
nological effects, and viability in digestive tract [37]. 
Genes encoding antibiotic resistance are used as selectable 
marker. But, it is emphasized that these markers should not 
be inserted in live microorganisms which are present in 
foods. Otherwise, it should be approved that food 
components derived from such microorganism are free 
from viable cells [37]. 
International regulatory bodies: Overall 
view 
Using GM products are doubtful because of 
contradictory views. In the one hand, it is verified by some 
scientists and organizations with no adverse effect while 
some other departments decline their usage due to further 
possible consequences. Although no distinct law rules out 
their processing and market release, it does not mean that 
no harmful consequence would occur in the future. It 
should be kept in mind that all potential hazards and risks 
must be considered in advance. Overall caution is a fact 
that is implemented by the European Union by conducting 
a risk assessment and management protocol. European 
Union is concerned regarding GMOs processing and 
demands a robust management [10]. American governors 
and investors are enthusiastic about GM food trade and 
regulations. In 2015, Barak Obama directed three federal 
agencies responsible for biotechnology -Environmental 
Protection Agency, Food and Drug Administration, and 
Department of Agriculture- to upgrade current regulations, 
conduct a prolonged strategy for the future of bio-
technology, and commission expert committee for inves-
tigation of future overview of biotechnology products to 
support former efforts [59]. 
However, international agencies are responsible for 
their international acceptance, standardization, and advice. 
The Cartagena Protocol on Biosafety is the main resource 
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associated with living modified organisms derived from 
modern biotechnology. In 2000, Cartagena Protocol on 
Biosafety was adopted by Convention on Biological 
Diversity parties in order to protect biological diversity 
from potential risks arising from living modified organisms 
derived from modern biotechnology. It provides necessary 
information for countries in making decision for import of 
GM products. Biosafety Clearing-House is established by 
Cartagena Protocol on Biosafety to assist countries in 
sharing information [36]. Other bodies are Organization 
for Economic Cooperation and Development (OECD), 
WHO, FAO, EFSA, and Codex Alimentarius Commission 
[60,61]. More than 20 stacked GM crops were evaluated 
by European Food Safety Authority as a robust admin-
istration in risk assessment. The results have shown no 
adverse consequences associated with the interaction of 
single traits with regard to compositional, agronomic and 
phenotypic alterations [62]. 
In 1988, the United States National Research Council 
(US NRC) concluded that the final GM products should be 
a base for making decision on potential environmental 
hazards and risks of GMOs, not the process by which the 
product is achieved. They also believe that the process is 
applicable in finding out the products characteristics [63]. 
According to this report, field trials should consider three 
scopes: 
 Acquaintance: a general knowledge about traits, 
events, and their possible effects on the environment. 
 Control action: in some cases, there should be the 
ability of confinement or control of GMOs spread, if 
necessary. 
 Risk estimation: for evaluation of further harmful 
consequences if the crop would be out of control or 
confinement. 
2. Conclusion 
GM crops are widely produced and used worldwide 
and their benefits are not negligible. Considering all 
concerns and doubts related to GM technology, inter-
national agencies have accepted usage of some products 
prepared by specific genetic occurrences based on in vitro 
and in vivo trials. Beside potential promises and challenges 
mentioned in the current review, it should be noted that 
today there is a severe crisis of water paucity and reduced 
rainfall in a vast geographical regions. Also, shortage of 
food supply in some countries and malnutrition in others 
draw the attention to the food security challenges. Making 
new changes in genome transcription toward production of 
high yielded crops with favorable metabolites such as 
higher amounts of oleic acid in vegetable oils, and crops 
fortified with some vitamins and minerals are some 
examples of promising roles of this technology in erad-
ication of famine and malnutrition. However, more safety 
assessment studies of GM technology are required to 
evaluate the possibility of any unintended effects in the 
future. 
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 ها، و ارزیابی خطرهای غذایی تراریخته: پیامدهای مفید، چالشفراورده
 1، معصومه مسلمی2، شهزاد کوسر1منوچهر دادگرنژاد
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 تاریخچه مقاله
 2112می  22 دریافت  
 2112ژوئن  12داوری    
 2112آگوست  6ش   رپذی
 چکیده 
 21های تراریخته در حوزه کشاورزی و صنعت غذا به سالهای پایانی قرن کاربرد سازواره سابقه و هدف:
گردد. از آن زمان به بعد فواید و سالمت محصوالت به دست آمده از این فناوری یک موضوع برمی میالدی
های مختلف این نوع بحث برانگیز در مجامع عمومی شده است. در این مقاله تالش شده است تا جنبه
 .ها و غذاها مورد بررسی قرار گیردسازواره
ای در مقابله با مشکالت کشاورزی شامل قوهلک توانایی بای اصالح ژنتیفناور :گیریها و نتیجهیافته
ها، تحمل موضوعات حیاتی و غیرحیاتی دارد که این مهم از طریق افزایش مقاومت به آفات و علف کش
ای دست یافتنی است. در کنار این فواید هایت افزایش بازده و کیفیت تغذیهخشکسالی، رسیدن سریع، و در ن
ها ای اخیر تعدادی از خطرات بالقوه انسانی، جانوری و زیست محیطی برای این سازوارههمهم، در طول دهه
یا غذاها مطرح شده است. با این حال، شواهد علمی کافی در مورد اثبات اثرات مضر آنها بر سالمتی انسان و 
ات جدید( برای ها و مقررهای علمی و مدیریتی جدید )فناوریحیوان ارائه نشده است. در عین حال، روش
ها ها نظیر سازگاری تدریجی آفتتعدیل برخی خطرات احتمالی زیست محیطی ارائه شده است. برخی چالش
بندی ژن و کاربرد پرایمرهایی که به خوبی با جزء مکمل کارگیری تکنیک پناهگاه، هرمهبا ژن تغییریافته با ب
سازی یا تغییر نتایج ناخواسته شامل خاموشی ژن، فعالای که شوند به گونهخود در ساختار ژنتیک جفت می
های غیرهدف را به حداقل ممکن برساند قابل مرتفع شدن هستند. البته این بدان معنی نیست ساختار بخش
که در آینده هیچ گونه اثرات مضر شناخته نشود. بنابراین، همواره الزم است پیش از ورود محصوالت 
بی خطر آنها انجام گرفته و حتی بعد از عرضه آنها پایش مستمر به منظور پیشگیری از تراریخته به بازار ارزیا
مشکالت احتمالی صورت پذیرد. در مجموع، کاربرد ایمن این فناوری و محصوالت تراریخته با در نظر گرفتن 
گیری از بهره المللی ارزیابی خطرات سالمتی و زیست محیطی بهقابل قبول ملی و بین هایتفاهم نامهتمام 
سنجی های سالمتفواید این تکنولوژی در کشاورزی، پزشکی و صنعت کمک خواهد کرد. با این حال، ارزیابی
 .باشنداین محصوالت همواره در حال انجام می
 .ندارد وجود منافعی تعارض هیچ که کنندمی اعالم نویسندگان :تعارض منافع
 واژگان کلیدی
 خطرات زیست محیطی ▪
 غذاهای اصالح ژنتیکی شده ▪
 های تراریختهفواید سازواره ▪
 خطرات سالمتی ▪
 ارزیابی خطر ▪
 کننده ایمنیعوامل نگران ▪
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